ReviewThe lancet. HIV2022

Use of integrase inhibitors in HIV-associated tuberculosis in high-burden settings: implementation challenges and research gaps.

Anushka Naidoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.